A new drug from AstraZeneca against Corona passes the last stage of trials

AstraZeneca Inc said on Monday that its antibody-mixture drug, the first protective dose other than vaccines against Covid-19, has achieved its main goals in last-stage trials by helping reduce severe cases of Covid-19 infection or death